Vericiguat combined with “new quadruple” therapy enhances cardiac function and life quality in patients with heart failure: a single-center prospective study
Vericiguat combined with the "new quadruple" therapy has a significant therapeutic effect on patients with heart failure caused by MI, DCM or VHD.
Authors
- Jia‐Bao Liu (ORCID: https://orcid.org/0000-0002-9620-7692)
- Yonghong Yong
- Di Zhao (ORCID: https://orcid.org/0000-0001-5912-1331)
- Lian‐Sheng Wang
- Yanjuan Zhang
Institutions
- Jiangsu Province Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2024-10-11
- DOI
- https://doi.org/10.3389/fcvm.2024.1476976
- Citations
- 6
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.41
Funders
- National Natural Science Foundation of China
- Government of Jiangsu Province
- Natural Science Foundation of Jiangsu Province